Rapamycin inhibits AR signaling pathway in prostate cancer by interacting with the FK1 domain of FKBP51

Jing Zhang, Dan Wu, Yongxing He, Lanlan Li, Shanhui Liu, Jianzhong Lu, Huiming Gui, Yuhan Wang, Yan Tao, Hanzhang Wang, Dharam Kaushik, Ronald Rodriguez, Zhiping Wang

Producción científica: Articlerevisión exhaustiva

8 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'Rapamycin inhibits AR signaling pathway in prostate cancer by interacting with the FK1 domain of FKBP51'. En conjunto forman una huella única.

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science